Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Endocrine Disorders » Adiponectin: Production, Regulation and Roles in Disease Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Fetal Alcohol Syndrome: Recognition, Differential Diagnosis and Long-Term Effects
$73.80
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Hyperlipidemia induced in regucalcin transgenic rats: Involvement of adiponectin (pp. 105-120)
Tell A Friend
 
Tell someone you know about this product.
Hyperlipidemia induced in regucalcin transgenic rats: Involvement of adiponectin (pp. 105-120) $100.00
Authors:  (Masayoshi Yamaguchi)
Abstract:
Regucalcin is known as a regulatory protein in various intracellular signaling systems. Regucalcin transgenic (TG) rat was generated to determine the role of regucalcin in metabolic disorders. Regucalcin TG rat has been found to induce hyperlipidemia with increasing age (14 to 50 weeks); serum triglyceride, high-density lipoprotein (HDL)-cholesterol, free fatty acid, albumin, and calcium concentrations are markedly increased in the TG male and female rats with increasing age. The decrease in lipid and glycogen contents in the liver tissues was induced in regucalcin TG rats. The expression of leptin mRNA in the adipose and liver tissues was decreased in regucalcin TG rats of 50 weeks old. Adiponectin mRNA levels were not changed in the adipose tissues of regucalcin TG rats of 50 weeks old, while its expression was decreased in the liver tissues. Leptin and adiponectin are adipokines that are involved in lipid metabolism. These decreases may be partly involved in the hyperlipidemia induced in regucalcin TG rats. Moreover, overexpression of regucalcin has been shown to enhance glucose utilization and lipid production in the cloned rat hepatoma H4-II-E cells in vitro, and insulin resistance is seen in the cells. The expression of glucose transporter 2 mRNA was increased in the transfectants which overexpress regucalcin, while the expressions of insulin receptor and phosphatidylinositol 3-kinase mRNAs that are involved in insulin signaling. It is proposed that regucalcin is related to hyperlipidemia and that the
regucalcin TG rat model may be useful to determine the pathophysiological state and the development of therapeutic tool for hyperlipidemia. 


Available Options:
Version:
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2021

Hyperlipidemia induced in regucalcin transgenic rats: Involvement of adiponectin (pp. 105-120)